EXS4318
id:
exs4318-234-14885325
title:
EXS4318
text:
EXS4318 is a selective PKC theta inhibitor that is potentially first-in-class medication. Developed by Exscientia, it was licensed to Bristol Myers Squibb. In 2023, it entered clinical trials in humans.
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/EXS4318
date created:
date modified:
2023-11-28T02:14:47Z
main entity:
{"identifier":"Q123481127","url":"https://www.wikidata.org/entity/Q123481127"}
image:
fields total:
13
integrity:
13